Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Mar 24, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how nutritional issues affect patients with pancreatic cancer (specifically pancreatic adenocarcinoma) before and after surgery. Many patients in this situation may not get the nutrition they need, which can complicate their recovery and overall health. The trial aims to find out how common malnutrition is among these patients, how it impacts their recovery and health risks during surgery, and how nutrition is currently managed. Based on the findings, the researchers hope to design future studies to explore better ways to provide nutritional support.
To be eligible for this trial, participants must be at least 18 years old, have a confirmed diagnosis of pancreatic adenocarcinoma, and be candidates for curative surgery. They should have had surgery at a specific hospital in Strasbourg between January 2018 and December 2022. Participants can expect to share their health data for research purposes if they consent to it. Importantly, this study is currently looking for volunteers, and all participants will be contributing to important research that could improve nutrition management for future patients undergoing similar treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Major subject (≥18 years old)
- • Subject with pancreatic adenocarcinoma authenticated by pathology
- • Subject candidate for curative surgical treatment
- • Subject operated on in the visceral and digestive surgery department, NHC Strasbourg, during the period from January 1, 2018 to December 31, 2022
- • Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.
- Exclusion criteria:
- • Subject having expressed opposition to participating in the study
- • Subject presenting a metastatic form or one not accessible to surgical treatment considered curative of pancreatic adenocarcinoma
- • Subject under guardianship or curatorship
- • Subje
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported